Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03619421 · ClinicalTrials.gov registry record · NA

Zinc Supplement Before or With Food in Generally Healthy Men

A NA study of Inflammation and Dyslipidemias, sponsored by UCSF Benioff Children's Hospital Oakland.

Completed
Registry status
NA
Development phase
35
Enrollment target
1
Study location

NCT03619421: Completed NA study of Inflammation and Dyslipidemias, sponsored by UCSF Benioff Children's Hospital Oakland.

NCT03619421 is a NA study of Inflammation and Dyslipidemias that has completed, run by UCSF Benioff Children's Hospital Oakland. The registered enrollment target is 35 participants, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03619421, a NA study of Inflammation and Dyslipidemias, has completed, sponsored by UCSF Benioff Children's Hospital Oakland.

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the influence of food consumption timing on the body's response to a zinc supplement

Primary Outcome

Change in plasma zinc

Interventions

  • DIETARY_SUPPLEMENT Zinc supplement

Study Locations (1)

California

  • UCSF Benioff Children's Hospital Oakland Research Institute - Oakland

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2018-08-21
Est. Completion 2019-04-15
Phase NA

What the finished NCT03619421 record still lists

NCT03619421 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (88% lower).

The record links to 4 conditions, with Inflammation appearing as the primary indexed condition, and to 1 intervention - of which Zinc supplement is the first listed.

NCT03619421 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT03619421 about?

NCT03619421 is a clinical study titled "Zinc Supplement Before or With Food in Generally Healthy Men". The purpose of this study is to determine the influence of food consumption timing on the body's response to a zinc supplement

What is the current status of trial NCT03619421?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2018-08-21. Estimated completion is 2019-04-15.

What conditions does trial NCT03619421 study?

This clinical trial studies the following conditions: Inflammation, Dyslipidemias, Zinc Deficiency, Zinc Excess.

What interventions are being tested in trial NCT03619421?

The interventions under investigation include: Zinc supplement (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03619421?

This trial is sponsored by UCSF Benioff Children's Hospital Oakland, which has 52 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03619421 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Inflammation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03619421's enrollment target sits among peer trials

35 92nd of 132 higher than 39 of 132 other Inflammation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Inflammation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01697371 · 35 participants · NA

    Proton Therapy in the Treatment of Liver Metastases

  • NCT01940757 · 35 participants · Phase 1

    Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae

  • NCT02235857 · 35 participants · NA

    Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

  • NCT02637934 · 35 participants · Phase 1

    Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03619421, the US trial registry maintained by the National Library of Medicine. NCT03619421 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.